128 related articles for article (PubMed ID: 15556058)
21. beta-Blocker therapy in heart failure.
Doughty RN
Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
[TBL] [Abstract][Full Text] [Related]
22. Using Cardicor as first-line therapy in heart failure : CiBis iii.
Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
[No Abstract] [Full Text] [Related]
23. Hawthorn extract improves chronic heart failure.
Eaton LJ; Kinkade S
J Fam Pract; 2003 Oct; 52(10):753-4. PubMed ID: 14529593
[No Abstract] [Full Text] [Related]
24. What is the optimal medical management of ischemic heart failure?
Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
[TBL] [Abstract][Full Text] [Related]
25. [Combination therapy with PDE III inhibitor for heart failure].
Watanabe H; Kajimoto K; Kawana M
Nihon Rinsho; 2007 May; 65 Suppl 5():134-9. PubMed ID: 17571377
[No Abstract] [Full Text] [Related]
26. Heart failure.
McKelvie R
Clin Evid; 2002 Jun; (7):57-78. PubMed ID: 12230638
[No Abstract] [Full Text] [Related]
27. Treatment of heart failure with preserved systolic function.
de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
[TBL] [Abstract][Full Text] [Related]
28. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
29. Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure.
Bader FM; Gilbert EM; Mehta NA; Bristow MR
Congest Heart Fail; 2010; 16(6):265-70. PubMed ID: 21091611
[TBL] [Abstract][Full Text] [Related]
30. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial.
Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M;
Eur J Heart Fail; 2008 Dec; 10(12):1255-63. PubMed ID: 19019730
[TBL] [Abstract][Full Text] [Related]
31. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
Haas SJ; Vos T; Gilbert RE; Krum H
Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
[TBL] [Abstract][Full Text] [Related]
32. Update of recent clinical trials in heart failure and myocardial infarction.
Richardson M; Cockburn N; Cleland JG
Eur J Heart Fail; 1999 Mar; 1(1):109-15. PubMed ID: 10937988
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure.
Parikh KS; Piccini JP
Curr Heart Fail Rep; 2017 Dec; 14(6):529-535. PubMed ID: 28975475
[TBL] [Abstract][Full Text] [Related]
34. Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial.
Zick SM; Vautaw BM; Gillespie B; Aaronson KD
Eur J Heart Fail; 2009 Oct; 11(10):990-9. PubMed ID: 19789403
[TBL] [Abstract][Full Text] [Related]
35. Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE.
Cleland JG; Coletta AP; Lammiman M; Witte KK; Loh H; Nasir M; Clark AL
Eur J Heart Fail; 2005 Oct; 7(6):1070-5. PubMed ID: 16227146
[TBL] [Abstract][Full Text] [Related]
36. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
Coletta AP; Tin L; Loh PH; Clark AL; Cleland JG
Eur J Heart Fail; 2006 Aug; 8(5):547-9. PubMed ID: 16887387
[TBL] [Abstract][Full Text] [Related]
37. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
Thackray S; Witte K; Clark AL; Cleland JG
Eur J Heart Fail; 2000 Jun; 2(2):209-12. PubMed ID: 10856736
[TBL] [Abstract][Full Text] [Related]
38. Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF.
Cleland JG; Coletta AP; Clark AL
Eur J Heart Fail; 2006 Nov; 8(7):764-6. PubMed ID: 17049305
[TBL] [Abstract][Full Text] [Related]
39. Drugs for chronic heart failure.
Med Lett Drugs Ther; 2015 Jan; 57(1460):9-13. PubMed ID: 25581106
[No Abstract] [Full Text] [Related]
40. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
Habs M
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
